Scientific and Ethical Considerations in Trial Design for Investigational Agents for the Treatment of Human Immunodeficiency Virus Infection-Reference-Cited by-同舟云学术

Scientific and Ethical Considerations in Trial Design for Investigational Agents for the Treatment of Human Immunodeficiency Virus Infection

Published:2003-01-15 Issue:2 Volume:36 Page:201-206
ISSN:1058-4838
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:CLIN INFECT DIS

Author:

Feinberg Judith,Japour Anthony J.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

http://academic.oup.com/cid/article-pdf/36/2/201/899790/36-2-201.pdf

Reference28 articles.

1. Infectious Diseases: Considerations for the 21st Century

2. National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. The Belmont report. Washington, DC: US Government Printing Office, 1979.

3. Jones JH. Bad blood: the Tuskegee syphilis experiment. New York: The Free Press, 1993.

4. Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. Available at http://www.hivatis.org. Updated 13 August 2001.

5. Antiretroviral Therapy in Adults

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multi-site clinical evaluation of the Xpert® HIV-1 viral load assay;Journal of Clinical Virology;2016-07

2. Meta-Analysis of Gender Differences in Efficacy Outcomes for HIV-Positive Subjects in Randomized Controlled Clinical Trials of Antiretroviral Therapy (2000–2008);AIDS Patient Care and STDs;2012-08

3. Pharmacokinetics and Pharmacodynamics of TBR-652, a Novel CCR5 Antagonist, in HIV-1-Infected, Antiretroviral Treatment-Experienced, CCR5 Antagonist-Naïve Patients;Antimicrobial Agents and Chemotherapy;2011-06

4. Implementing the number needed to harm in clinical practice: risk of myocardial infarction in HIV-1-infected patients treated with abacavir;HIV Medicine;2010-03

5. VIEWS OF THE PROCESS AND CONTENT OF ETHICAL REVIEWS OF HIV VACCINE TRIALS AMONG MEMBERS OF US INSTITUTIONAL REVIEW BOARDS AND SOUTH AFRICAN RESEARCH ETHICS COMMITTEES;Developing World Bioethics;2008-12